|
BOARD OF DIRECTORS
Gary R. Eldridge, Jr.
President and CEO
John H. Ferring, IV
Board Member
David B. Mueller
Board Member
Stephen M. Notestine Sr.
Board Member
William C. Rusnack
Board Member
Peter F. Drake, Ph.D.
Board Member
Stephen L. Trampe
Chairman of the Board
|
| Gary Eldridge, President & CEO |
| Gary Eldridge has been the President and Chief Executive Officer of Sequoia Sciences since its inception in 1999. He co-founded Sequoia based upon his market research of the use of natural products in modern drug discovery programs. Gary established strategic research collaborations with the Missouri Botanical Garden and Washington University. He negotiated research collaborations and service agreements with pharmaceutical and biotechnology companies. He co-developed and led the validation of the company's platform technologies including its library production processes, compound isolation strategies and procedures, and structure elucidation strategies. Gary leads the strategic direction of Sequoia and is currently managing the research and development activities of its antibacterial program. Before starting Sequoia, he worked as an analytical chemist within the pharmaceutical industry at Ligand Pharmaceuticals and Amylin Pharmaceuticals. Gary received a B.S. in Chemistry from Butler University in Indianapolis, Indiana. |
|
